Private Equity Archives - Gilde Healthcare

Menu
Menu
Home

latest news
Private Equity

Gilde Healthcare invests in German precision surgical instruments contract manufacturer Koscher & Würtz

The acquisition of Koscher & Würtz represents a major step for Gilde Healthcare in forming a market leading instrument contract manufacturing group, following its initial investment in Chr. Diener, less than 18 months ago. Koscher & Würtz (K&W) will join as a group company next to Chr. Diener, together employing about 300 highly qualified staff members. By joining forces, K&W...
November 20, 2023

Gilde Healthcare company Noema Pharma raises CHF 103 million ($112 million)

test Gilde Healthcare, a leading specialized healthcare investor, today announced that its portfolio company Noema Pharma, has raised an oversubscribed CHF 103 million ($112 million) Series B financing round from new and existing investors. Noema Pharma is a clinical-stage biopharma company targeting debilitating central nervous system (CNS) disorders. The financing round was completed by an international […]

Gilde Healthcare company Synexa Life Sciences celebrates its 20th anniversary

test Two decades of advancing drug development programs through specialist biomarker and bioanalytical insights Synexa Life Sciences, a specialist biomarker and bioanalysis services provider, celebrates its 20th anniversary on March the 3rd 2023. Since its inception in 2003, Synexa Life Sciences has become a trusted partner to pharmaceutical, biotech, academic and non-profit organizations all over the […]

Gilde Healthcare sells its stake in Zetacom to facilitate a merger with Detron

The Private Equity fund of Gilde Healthcare, the leading European specialist healthcare investor, has reached an agreement to sell its majority stake in Zetacom to Avedon Capital, a leading mid-market private equity firm in the Benelux and DACH-region. Avedon will merge the company with Detron, an independent...

Gilde Healthcare Acquires Sanquin Reagents

The specialized private equity fund invests in scaling-up production and development of new medical tests

Gilde Healthcare bolsters its Private Equity team in Frankfurt office

Dutch sector specialist Gilde Healthcare announces two new hires to its private equity team in Germany, following the recent close of its new €518m lower mid-market fund Gilde Healthcare Private Equity IV. With the recruitment of Martin von Berg as Investment Manager and Lara Hilgert as Investment...

Gilde Healthcare company Zetacom acquires communication specialist Ooperon

Dutch communication system integrator Zetacom B.V. announced the acquisition of communication specialist Ooperon B.V.

Gilde Healthcare invests in German precision surgical instruments contract manufacturer Chr. Diener

Leading contract manufacturer of highly complex, customer-specific, surgical instruments partners with Gilde Healthcare to further build on the company’s 122-year heritage.

Gilde Healthcare portfolio company Synexa Life Sciences acquires Finnish CRO Syrinx Bioanalytics to expand bioanalysis capabilities in clinical drug development

Expansion of leading biomarker and bioanalysis company enhances bioanalytical solutions and specifically solutions for targeted radiopharmaceuticals.
Loading...
These were all messages
7270d7b6c2